Hosted on MSN2h
William Blair Initiates Coverage of Mersana Therapeutics (MRSN) with Outperform Recommendation
Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a ...
Hosted on MSN14h
William Blair Upgrades Tempur Sealy International (TPX)
Fintel reports that on February 5, 2025, William Blair upgraded their outlook for Tempur Sealy International (NYSE:TPX) from ...
What is William Blair’s Forecast for TWST Q2 Earnings?
Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...
Mersana Therapeutics initiated with an Outperform at William Blair
William Blair initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating.Maximize Your Portfolio with Data Driven ...
William Blair Expects Reduced Earnings for Sera Prognostics
Equities researchers at William Blair cut their Q3 2025 earnings estimates for Sera Prognostics in a report released on Monday, February 3rd. William Blair analyst A. Brackmann now expects that the ...
Williamsburg-area school board might consider changing name of James Blair Middle School
WJCC Schools last changed the name of one of its schools in 2017. Before it was Laurel Lane Elementary, the elementary school ...
10 Best Human Resources Stocks To Invest In
According to a report by Reuters on January 23, the number of citizens in the United States applying for unemployment ...
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma.
Who’s who in tariff town
Props to BOB GORDON, MALCOLM MCKAY, ROBERT MCDOUGALL, GORDAN RANDALL, RAY DEL BIANCO, SHAUGHN MCARTHUR, MARCEL MARCOTTE, ...